Cargando…
CRISPR/Cas9 Genome-Editing Technology and Potential Clinical Application in Gastric Cancer
Gastric cancer is the subject of clinical and basic studies due to its high incidence and mortality rates worldwide. Due to the diagnosis occurring in advanced stages and the classic treatment methodologies such as gastrectomy and chemotherapy, they are extremely aggressive and limit the quality of...
Autores principales: | Almeida, Renata Sanches, Wisnieski, Fernanda, Takao Real Karia, Bruno, Smith, Marilia Arruda Cardoso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690943/ https://www.ncbi.nlm.nih.gov/pubmed/36360266 http://dx.doi.org/10.3390/genes13112029 |
Ejemplares similares
-
The Complex Network between MYC Oncogene and microRNAs in Gastric Cancer: An Overview
por: Anauate, Ana Carolina, et al.
Publicado: (2020) -
Bioethical issues in genome editing by CRISPR-Cas9 technology
por: AYANOĞLU, Fatma Betül, et al.
Publicado: (2020) -
Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology
por: Burgio, Gaetan
Publicado: (2018) -
Edition of TFAM gene by CRISPR/Cas9 technology in bovine model
por: de Oliveira, Vanessa Cristina, et al.
Publicado: (2019) -
Efficient Genome Editing Using CRISPR/Cas9 Technology in Chicory
por: Bernard, Guillaume, et al.
Publicado: (2019)